Two-dimensional agnor evaluation as a prognostic variable in urinary bladder carcinoma: A different approach via total agnor area/nucleus area per cell

Micron

Volumn 38, Issue 6, 2007, Pages 674-679

  Cucer, Nurhan ^a   Imamoglu, Nalan ^a   Tozak, Halime ^a   Demirtas, Halil ^a   Sarac, Fulya ^a   Tatlisen, Atila ^a   Öztürk, Figen ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

AgNOR; Bladder cancer; Image analysis; Microscopy; Morphometry; Prognosis

Indexed keywords

BLADDER CANCER; MORPHOMETRY; PROGNOSIS; VIDEO CAPTURE;

BIOLOGICAL ORGANS; CELLS; IMAGE ANALYSIS; MICROSCOPIC EXAMINATION; TUMORS; VIDEO CAMERAS;

ONCOLOGY;

CELL NUCLEUS ANTIGEN; NUCLEAR PROTEIN; NUCLEOLAR ORGANIZER REGION ASSOCIATED PROTEINS; UNCLASSIFIED DRUG;

ARTICLE; BLADDER TUMOR; CANCER STAGING; CELL NUCLEUS; CHROMOSOME NOR; EVALUATION; HUMAN; IMAGE PROCESSING; MALE; METABOLISM; METHODOLOGY; MORTALITY; PATHOLOGY; PROGNOSIS; SILVER STAINING; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

ANTIGENS, NUCLEAR; CARCINOMA, TRANSITIONAL CELL; CELL NUCLEUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; NEOPLASM STAGING; NUCLEAR PROTEINS; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; SILVER STAINING; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 34247164602     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2006.08.002     Document Type: Article

References (23)

1. Derenzini M., Farabegoli F., and Treré D. Relationship between interphase AgNOR distribution and nucleolar size in cancer cells. J. Mol. Histol. (Historical Arch.) 24 (1992) 951-956
2. Gordon K.C. In: Bancroft J.D., Stevens A., and Turner D.R. (Eds). Theory and Practice of Histological Tecniques. 3rd ed. (1990), Churchill Livingstone, London 3743 (chapter 3)
3. Han M., and Shoenberg M. The use of molecular diagnostics in bladder cancer. Urol. Oncol. 5 (2000) 87-92
4. Hao C.F., Wang Z.H., Yun J.P., et al. The measurement of AgNORs in human glioma cells. Anticancer Res. 20 (2000) 1599-1602
5. Iwata H., Otoshi T., Takada N., Mur T., Tamano S., Watanabe T., Katsura Y., and Fukushima S. Validation of silver-stained nucleolar organizer regions for evaluation of invasive character of urinary bladder carcinoma in rats and mice. Urol. Res. 23 (1995) 27-32
6. Korneyev I.A., Mamaev N.N., Kozlov M.G., Rybakova M.G., and Al-Shukri S.H. Interphase argyrophylic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumors. J. Clin. Pathol.; Mol. Pathol. 53 (2000) 129-132
7. Kuno T., Hirose Y., Yamada Y., Hata K., Qiang S.H., Asano N., Oyama T., Zhi H.L., Iwasaki T., Kobayashi H., and Mori H. Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran. Oncol. Rep. 15 3 (2006) 533-538
8. Lindner L.E. Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). J. Histochem. Cytochem. 41 (1993) 439-445
9. Martin H., Hufnagl P., Beil M., Wenzelides K., Gottschalk J., and Rahn W. Nucleolus organizer region-associated proteins in cancer cells. Quantitative investigations on gliomas, meningiomas, urinary bladder carcinomas and pleural. Anal. Quant. Cytol. Histol. 14 (1992) 312-319
10. Modlich O., Prisack H.-B., Pitschke G., Ramp U., Ackermann R., Bujar H., Vögeli T.A., and Grimm V.-O. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles. Clin. Cancer Res. 10 (2004) 3410-3421
11. Pich A., Chiusa L., Camino A., and Navone R. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinoma. Virchows Arch. 424 (1994) 143-148
12. Pich A., Chiusa L., and Margaria E. Prognostic relevance of AgNORs in tumor pathology. Micron 31 (2000) 133-141
13. Pich A., Chiusa L., Formiconi A., Galliano D., Bortolin P., Comino A., and Navone R. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of bladder. Cancer 15 (2002) 784-790
14. Rosai J. Urinary tract. Ackerman's Surgical Pathology. 8th ed. vol. 1 (1996), Mosby Year Book Inc., St. Louis pp. 1197-1201 (chapter 17)
15. Raman J.D., Ng C.K., Boorjian S.A., Vaughan E.D., Sosa R.E., and Scherr D.S. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int. 96 (2005) 1031-1035
16. Ruschoff J. Nucleolus organizer regions in pathomorphologic tumor diagnosis. Veroff. Pathol. 139 (1992) 1-144
17. Ruschoff J., Knuhel R., and Hofstadter F. AgNOR quantification with special reference staining patterns. Zentralbl Path. 140 (1994) 23-30
18. Shiina H., Urakami S., Shirakawa H., et al. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer. Eur. Urol. 29 (1996) 99-105
19. Stein J.P., Grossfeld G.D., Ginsberg D.A., et al. Prognostic markers in bladder cancer: a contemporary review of the literature. J. Urol. 160 (1998) 615-659
20. Tomobe M., Shimazui T., Uchida K., Hinotsu S., and Akaza H. Argyrophylic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor. J. Urol. 162 (1999) 63-68
21. Treré D., Pession A., and Derenzini M. The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp. Cell Res. 184 (1989) 131-137
22. Tuccari G., Abbona G.C., Guiffre G., Guiffre G., Papotti M., Gasparri G., Barresi G., and Bussolati G. AgNOR quantity as a prognostic tool in hyperplastic and neoplastic parathyroid glands. Virchows Arch. 437 (2000) 298-303
23. World Health Organization. Histological tyiping of urinary bladder tumors. International classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am. J. Surg. Pathol. 22 (1998) 1435